Evaluation of tendon and ligament microstructure and mechanical properties in a canine model of mucopolysaccharidosis I.
Yian Khai LauKeerthana IyerSnehal S ShetyeChet S FridayGeorge R DodgeMichael W HastMargret L CasalRahul GawriLachlan J SmithPublished in: Journal of orthopaedic research : official publication of the Orthopaedic Research Society (2024)
Mucopolysaccharidosis (MPS) I is a lysosomal storage disorder characterized by deficient alpha-l-iduronidase activity, leading to abnormal accumulation of glycosaminoglycans (GAGs) in cells and tissues. Synovial joint disease is prevalent and significantly reduces patient quality of life. There is a strong clinical need for improved treatment approaches that specifically target joint tissues; however, their development is hampered by poor understanding of underlying disease pathophysiology, including how pathological changes to component tissues contribute to overall joint dysfunction. Ligaments and tendons, in particular, have received very little attention, despite the critical roles of these tissues in joint stability and biomechanical function. The goal of this study was to leverage the naturally canine model to undertake functional and structural assessments of the anterior (cranial) cruciate ligament (CCL) and Achilles tendon in MPS I. Tissues were obtained postmortem from 12-month-old MPS I and control dogs and tested to failure in uniaxial tension. Both CCLs and Achilles tendons from MPS I animals exhibited significantly lower stiffness and failure properties compared to those from healthy controls. Histological examination revealed multiple pathological abnormalities, including collagen fiber disorganization, increased cellularity and vascularity, and elevated GAG content in both tissues. Clinically, animals exhibited mobility deficits, including abnormal gait, which was associated with hyperextensibility of the stifle and hock joints. These findings demonstrate that pathological changes to both ligaments and tendons contribute to abnormal joint function in MPS I, and suggest that effective clinical management of joint disease in patients should incorporate treatments targeting these tissues.
Keyphrases
- gene expression
- end stage renal disease
- traumatic brain injury
- chronic kidney disease
- total knee arthroplasty
- induced apoptosis
- replacement therapy
- ejection fraction
- peritoneal dialysis
- white matter
- cell proliferation
- prognostic factors
- multiple sclerosis
- oxidative stress
- cell death
- liver injury
- cancer therapy
- smoking cessation